StockDuty Jul 01, 2026 09:04 AM ET
CatalystEarnings

$FDX — HOLD 📊 | 6 MONTHS THESIS

FDX
$313.89
+0.24%
$FDX — HOLD 📊 | 6 MONTHS THESIS 🧭 Conviction: MED FedEx Corporation, together with its subsidiaries, provides transportation, e-commerce, and business services in the United States and internationally. 🎯 FQ4 FY2027 (ends May) | reported Jun 23 | Rev $24.0B | EPS $6.31 vs $5.91 🟢 | Margin 6.6% 💡 Consensus expected tepid results; the beat may have been fueled by one-time cost savings or volume spikes. The market might extrapolate this quarter into overly optimistic forward estimates, while the reality of sustained margin pressure in a competitive logistics industry is underappreciated. 🏢 Business Quality: 5/10 📊 Valuation: fair 🔮 Catalyst: Q1 FY2027 earnings report (expected September 2026) ⚖️ Hold — the EPS beat appears unsustainable without structural margin improvement; valuation is fair, not cheap, and upside to $340 offers only 1.2x reward/risk. Await confirmation of margin expansion before adding. 📊 Our read: HOLD. Full analysis → https://stockduty.xyz/s/FDX0701
🧭 Conviction: MED
Sources
pipeline